OS Fund
Venture Capital
Active
Chicago, United States
48
21M
34
4.80
6
0.29
5
- Areas of investment
Summary
This organization was formed by Bryan Johnson, Jeff Klunzinger, Jeffrey Klunzinger. We also calculated 4 valuable employees in our database.
The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the OS Fund, startups are often financed by Founders Fund, Data Collective DCVC, Y Combinator. The meaningful sponsors for the fund in investment in the same round are Y Combinator, Founders Fund, Data Collective DCVC. In the next rounds fund is usually obtained by Y Combinator, Lux Capital, Data Collective DCVC.
Besides, a startup needs to be aged 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Therapeutics, Genetics. The fund has no exact preference in some founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. Among the most popular portfolio startups of the fund, we may highlight Cleversafe, Human Longevity, Ginkgo BioWorks.
The top amount of exits for fund were in 2018. The top activity for fund was in 2016. Despite it in 2019 the fund had an activity. Opposing the other organizations, this OS Fund works on 22 percentage points less the average amount of lead investments. Speaking about the real fund results, this VC is 3 percentage points less often commits exit comparing to other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in 7-12 investment rounds annually. The average startup value when the investment from OS Fund is 100-500 millions dollars.
Investor highlights
- Industry focus
- Stage focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Last fund
- Fund size
- USD 250000000
- Fund raised date
- 2018-08-07
Analytics
- Total investments
- 48
- Lead investments
- 6
- Exits
- 5
- Rounds per year
- 4.80
- Follow on index
- 0.29
- Investments by industry
- Biotechnology (31)
- Health Care (18)
- Health Diagnostics (10)
- Genetics (8)
- Medical (8) Show 62 more
- Investments by region
-
- United States (44)
- Canada (4)
- Peak activity year
- 2016
- Number of Unicorns
- 3
- Number of Decacorns
- 3
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Avg. valuation at time of investment
- 262M
- Group Appearance index
- 0.94
- Avg. company exit year
- 8
- Avg. multiplicator
- 6.21
- Strategy success index
- 0.40
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
01 Jan 2018 | Automotive, Infrastructure, Software, Artificial Intelligence, Developer Tools, Developer Platform, Blockchain, Developer APIs, Advanced Materials, Nanotechnology | Seed | 0 | United States, San Francisco | |
Kenota Health | 22 Aug 2016 | Biotechnology, Health Care, Health Diagnostics, Medical | Seed | Ontario, Kitchener, Canada | |
Ginkgo Bioworks | 18 Mar 2015 | Biotechnology, Chemical, Biopharma | Early Stage Venture | 9M | United States, Massachusetts, Boston |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.